First ever HIV immunotherapy, involving ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals, proves safe in human phase 1 clinical trial, as reported in the journal Molecular Therapy.

First ever HIV immunotherapy, involving ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals, proves safe in human phase 1 clinical trial, as reported in the journal Molecular Therapy.: https://ift.tt/2Dj6dnH Read more... https://ift.tt/2xy6qxY